Aptorum Group Ltd Cl A (APM) |
|
2.25 -0.05 (-2.17%)
|
10-23 23:18 |
|
Open: |
2.26 |
Pre. Close: |
2.3 |
|
High:
|
2.29 |
Low:
|
2.15 |
|
Volume:
|
455,006 |
Market Cap:
|
77M |
|
|
|
|
Aptorum Group Ltd. is a pharmaceutical company, which engages in the development and commercialization of therapeutic and diagnostic technologies. The company employs 39 full-time employees Along with subsidiaries, the Company operates its business through three segments. The Therapeutics segment is involved in the production and sale of drug molecules. The company also develops technologies for the treatment and diagnosis of human disease conditions in neurology, infectious diseases, gastroenterology, oncology and other disease areas. The Non Therapeutic segment is involved in the development of surgical robotics and medical devices. In addition, it is also involved in the provision of healthcare and clinic services, as well as operation of a medical center under the name of Talem. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
2.305 - 2.327 |
2.327 - 2.34 |
|
Low:
|
2.105 - 2.133 |
2.133 - 2.149 |
|
Close:
|
2.217 - 2.264 |
2.264 - 2.292 |
|
Technical analysis |
as of: 2020-10-23 4:40:38 PM |
|
Overall:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
| Target: |
Six months: 10.79 One year: 16.62 |
| Support: |
Support1: 1.16 Support2: 0.97 |
| Resistance: |
Resistance1: 9.24 Resistance2: 14.23 |
| Pivot: |
2.66  |
| Moving Average: |
MA(5): 2.42 MA(20): 2.70 
MA(100): 3.01 MA(250): 7.01 |
| MACD: |
MACD(12,26): 0.03 Signal(9): 0.09 |
| Stochastic oscillator: |
%K(14,3): 8.09 %D(3): 6.92 |
| RSI: |
RSI(14): 45.36 |
| 52-week: |
High: 18.25 Low: 1.16 Change(%): -85.7 |
| Average Vol(K): |
3-Month: 172355 10-Days: 67485 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.APM has closed below the lower band by 1.5%. If price is in a downtrend band; this downward trend in price might continue. However a short term pullback inside the band is likely. Bollinger Bands are 45.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to APM's normal range. The bands have been in this narrow range for 3 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Headline News |
Wed, 14 Oct 2020
This Covid-19 Connection Makes Aptorum Group Stock Intriguing - Investorplace.com
Tue, 13 Oct 2020
Aptorum Group Ltd (APM) Stock: Buy, Hold, or Sell? - InvestorsObserver
Wed, 07 Oct 2020
Is Aptorum Group Ltd (APM) Stock Near the Top of the Biotechnology Industry? - InvestorsObserver
Tue, 06 Oct 2020
Is Aptorum Group Ltd (APM) a Stock to Watch This Week? - InvestorsObserver
Mon, 05 Oct 2020
Should You Buy Aptorum Group Ltd (APM) in Biotechnology Industry? - InvestorsObserver
Mon, 05 Oct 2020
APM Stock Price – Aptorum Group Ltd soars 290% then collapses after venturing into infectious diseases - FXStreet
|
Financial Analysis |
| Growth |
n/a |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Outperform |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Underperform |
Price to Earnings: |
Underperform |
| Return on Equity: |
Underperform |
Debt to Equity: |
Neutral |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
11 |
| Shares Float (M) |
7 |
|
% Held by Insiders
|
37.66 |
|
% Held by Institutions
|
0.01 |
|
Shares Short (K)
|
40 |
|
Shares Short P. Month (K)
|
27 |
Stock Financials |
|
EPS
|
-0.536 |
|
EPS Est This Year
|
|
|
EPS Est Next Year
|
|
|
Book Value (p.s.)
|
0.650 |
|
Profit Margin
|
|
|
Operating Margin
|
-2935.77 |
|
Return on Assets (ttm)
|
-47.5 |
|
Return on Equity (ttm)
|
-84.1 |
|
Qtrly Rev. Growth
|
36.5 |
|
Gross Profit (p.s.)
|
-0.023 |
|
Sales Per Share
|
0.055 |
|
EBITDA (p.s.)
|
-1.497 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-13 |
|
Levered Free Cash Flow (M)
|
-7 |
Stock Valuations |
|
PE Ratio
|
-4.20 |
|
PEG Ratio
|
|
|
Price to Book value
|
3.46 |
|
Price to Sales
|
40.69 |
|
Price to Cash Flow
|
-1.94 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
